Vietnam Surgical Suture Market Report and Forecast 2026-2034

Study Period

2021-2034

Market (2025)

USD 41.37 Million

Market (2034)

USD 74.60 Million

CAGR

6.77%

Major Markets Players

CPT Sutures Co., Ltd., USM Healthcare, Medical Devices and Biomaterial Plant Joint Stock Company (MEDEP), Medtronic Vietnam, Johnson & Johnson Vietnam and Others

*Note: Partial List Randomly Ordered

Vietnam Surgical Suture Market Statistics and Insights

Vietnam Surgical Suture Market Insights & Analysis

The Vietnam Surgical Suture Market is anticipated to register a 6.77% CAGR during 2026–2034. The market size was valued at USD 41.37 million in 2025 and is projected to reach USD 74.60 million by 2034. Vietnam's healthcare sector is undergoing a significant structural transformation, fueled by the government's ambitious National Health Strategy, which has earmarked over VND 20 trillion (approximately USD 830 million) toward expanding hospital capacity, modernizing surgical facilities, and improving rural healthcare access through 2030.

This public investment is directly translating into higher volumes of surgical procedures across general surgery, orthopedics, cardiovascular care, and oncology, all of which depend heavily on reliable suturing solutions. Private sector investment is equally dynamic, with international hospital groups such as Vinmec and FV Hospital expanding their surgical departments in Ho Chi Minh City and Hanoi. The rising prevalence of non-communicable diseases, with diabetes alone affecting nearly 7 million Vietnamese adults as of 2024, continues to push surgical procedure volumes higher, anchoring sustained demand for both conventional suture threads and automated suturing devices well into the next decade.

Vietnam Surgical Suture Market Dynamics

Key Market Driver Rising Minimally Invasive Surgery Adoption

Vietnam has recorded a marked acceleration in the adoption of minimally invasive surgeries (MIS), including laparoscopic and robotic-assisted procedures, across major tertiary hospitals in Hanoi and Ho Chi Minh City. According to Vietnam Ministry of Health data, laparoscopic surgeries now constitute over 38% of elective procedures performed in Tier-1 public hospitals, up from approximately 22% in 2019.

This shift necessitates specialized suture thread formulations and precision automated suturing devices capable of operating through narrow-gauge instruments. Key players such as Medtronic Vietnam and Johnson & Johnson Vietnam have responded by introducing next-generation absorbable monofilament sutures engineered specifically for laparoscopic wound closure, widening the premium segment of the market significantly. The expansion of robotic surgery programs, notably at Cho Ray Hospital, which commissioned its third Da Vinci surgical system in 2024, further underpins the long-term demand trajectory for advanced suturing consumables in the country.

Major Industry Challenge Prevalence of Counterfeit Suture Products

A structurally significant challenge confronting the Vietnam Surgical Suture Market is the infiltration of counterfeit and substandard suture products through unregulated distribution networks, particularly in rural provinces and smaller private clinics. Vietnam's Drug Administration has flagged counterfeit suture threads as a recurring compliance issue, with non-genuine products often lacking critical properties such as sterility certification, tensile integrity, and biocompatibility validation.

These counterfeit products undercut legitimate pricing by 30–45%, diverting procurement budgets away from certified manufacturers and exposing patients to elevated infection and wound dehiscence risks. Established players including B.Braun Vietnam and CPT Sutures Co., Ltd. have had to invest in authentication technologies and authorized distributor programs to safeguard market share. Regulatory enforcement remains inconsistent outside major urban centers, creating a persistent structural drag on revenue capture for compliant manufacturers throughout the forecast period.

Emerging Trend Shaping Outlook Bioabsorbable and Antimicrobial Suture Innovation

The Vietnam Surgical Suture Market is experiencing a defining product evolution toward bioabsorbable and antimicrobial-coated sutures, mirroring advanced healthcare trends in Japan and South Korea. Bioabsorbable sutures, including polyglycolic acid (PGA) and polydioxanone (PDS) variants, are gaining traction across obstetric, pediatric cardiac, and soft-tissue surgeries as they eliminate the post-operative step of suture removal and reduce patient discomfort.

Simultaneously, triclosan-coated antimicrobial sutures are being increasingly specified by hospital procurement committees seeking to reduce surgical site infection (SSI) rates, which affect an estimated 3.2% of surgeries performed in Vietnamese public hospitals annually. Domestic manufacturer MEDEP is actively developing PGA suture production capacity, while international players are introducing dual-function bioabsorbable-antimicrobial sutures targeted at Vietnam's growing private hospital network, a trend that is expected to redefine premium product standards by 2028.

Vietnam Surgical Suture Market Segment-wise Analysis

The Vietnam Surgical Suture Market is structured across two primary segmentation frameworks, By Type and by End User, each reflecting distinct demand dynamics driven by Vietnam's evolving healthcare infrastructure, surgical specialty mix, and institutional procurement preferences. Understanding these segments is critical for stakeholders seeking to optimize product positioning and distribution strategies across the country's tiered healthcare system.

By Type

• Automated Suturing Devices
• Suture Thread

Suture Thread constitutes the dominant segment within the By Type classification, commanding approximately 63% of total market revenue in 2025. The segment's leadership reflects the foundational role of thread-based sutures across general surgery, obstetrics, and wound care, procedures that form the highest-volume surgical categories in Vietnamese public and private hospitals alike. Absorbable suture threads, especially those made from polyglycolic acid and chromic gut, are witnessing the fastest uptake due to the elimination of follow-up suture removal procedures, a meaningful advantage in resource-constrained district-level hospitals.

Non-absorbable threads, including nylon and polypropylene variants, retain strong demand in cardiovascular and ophthalmic surgeries due to their superior tensile strength and dimensional stability. Meanwhile, Automated Suturing Devices, comprising staplers and endoscopic suturing systems, account for the remaining approximately 37% of the By Type segment. This sub-segment is growing at a faster clip, driven by the rapid expansion of minimally invasive and robotic surgical programs in Vietnam's Tier-1 hospitals. The premium positioning and per-procedure cost of automated devices has so far limited their penetration to urban hospitals, but ongoing price rationalization and government procurement subsidies are expected to broaden adoption into secondary care settings by 2028.

By End User

• Hospitals & Clinics
• Ambulatory Care Centers
• Others

Hospitals & Clinics represent the dominant end-user segment, capturing an estimated 71% of total Vietnam Surgical Suture Market revenue in 2025. This dominance is structurally reinforced by the concentration of surgical infrastructure within Vietnam's 1,400+ public hospitals and the expanding network of private hospital groups such as Vinmec, Thu Cuc, and FV Hospital, all of which conduct the vast majority of the country's approximately 3.8 million annual inpatient surgical procedures.

The multi-specialty nature of hospital surgical departments, spanning orthopedics, general surgery, gynecology, and oncology, drives diverse and high-volume suture procurement needs, encompassing everything from bulk suture thread packs to specialized absorbable sutures for minimally invasive procedures. Ambulatory Care Centers constitute a growing secondary segment, currently holding approximately 19% of market share. Vietnam's government push toward shifting routine surgeries to outpatient settings, including cataract repairs, hernia corrections, and minor orthopedic interventions, is progressively increasing suture consumption in ambulatory facilities. The remaining 10% of market revenue is distributed across specialty clinics, dental practices, and other healthcare settings, with aesthetic and cosmetic surgery clinics emerging as a notably fast-growing contributor.

Regional Projection of Vietnam Surgical Suture Market

Vietnam's surgical suture demand is concentrated in the following regions:

• Northern Vietnam
• Southern Vietnam
• Central Vietnam

Northern Vietnam holds the leading regional share at approximately 44% of national market revenue in 2025, anchored by the dense concentration of tertiary hospitals, medical universities, and specialty surgical centers in Hanoi. The region's status as Vietnam's administrative and medical research hub drives disproportionate surgical volumes and, consequently, the highest per-facility suture consumption. The ongoing expansion of Bach Mai Hospital and Viet Duc University Hospital's surgical wings is further reinforcing Northern Vietnam's market leadership. Southern Vietnam follows closely, led by Ho Chi Minh City's vibrant private hospital ecosystem, while Central Vietnam represents the fastest-growing region as government investment channels new surgical infrastructure into Danang and surrounding provinces.

Vietnam Surgical Suture Market: Recent Development (2025)

• CPT Sutures Co., Ltd. expanded its absorbable suture production line, reporting a 14% revenue increase.
• B.Braun Vietnam Co., Ltd. posted an operating margin improvement of 210 basis points through enhanced local distribution.
• Johnson & Johnson Vietnam launched a triclosan-coated suture range specifically tailored for Vietnamese hospital protocols.
• Medtronic Vietnam partnered with Cho Ray Hospital to pilot automated suturing device procurement under a value-based agreement.

Vietnam Surgical Suture Market Future Outlook (2034)

The Vietnam Surgical Suture Market is poised for robust long-term expansion, expected to sustain a 6.77% CAGR through 2034, reaching a value of USD 74.60 million. Growth will be driven by Vietnam's continued healthcare infrastructure investment, rising surgical volumes across chronic disease categories, and the progressive shift toward bioabsorbable and antimicrobial suture technologies. Automation in surgical procedures will accelerate demand for next-generation suturing devices as robotic surgery programs extend from flagship hospitals into regional centers. AI-assisted surgical planning and smart suture monitoring systems, capable of sensing wound tension and healing progress in real time, are expected to emerge as premium differentiators by the end of the forecast period. Domestic manufacturing capacity is also anticipated to scale meaningfully, reducing import dependency and improving market access across Vietnam's rural and semi-urban healthcare segments.

Why Choose This Report?

• Provides a comprehensive overview of the overall market analysis, encompassing key trends, consumer behavior analysis, and risk assessment to support strategic decision-making.
• Provides accurate, up-to-date insights into market size, segmentation, and emerging opportunities, helping to minimize risk & capitalizing on growth.
• Gives deep understanding of target audience preferences, investment habits, and communication channels for enhanced product development & marketing effectiveness.
• Delivers competitive analysis & benchmarking, uncovering the strengths & weaknesses of market competitors to guide strategies.
• Consolidate comprehensive market intelligence, reducing reasoning & streamlining research efforts.
• Facilitates customized market segmentation & risk mitigation strategies, fine-tuned to the business objectives.
• Aids in identifying both market challenges & untapped opportunities within the industry to drive long-term business growth.
• Provides valuable information based on actual customer data & search trends.